:


Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Am J Gastroenterol 2000; 95:3053.

Cunningham D, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998; 352:1413.

De Gramont A, et al. Leucovorin and fluorouracil with or without oxalipla- tin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18:2938-2947.

Giardiello FM, et al. Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med 2002; 346:1054.

Goldberg RM, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Ann Intern Med 1998; 129:27.

Goldberg RM, et al. A randomized controlled trial of fluorouracil plus leu- covorin, irinotecan and oxaliplatin combinations in patients with previously untreated colorectal cancer. J Clin Oncol 2004; 22:23.

Hurwitz HI, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovo- rin for metastatic colorectal cancer. N Engl J Med 2004; 350:2335.

Kabbinavar F, et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LValone in patients with metastatic colorectal cancer. J Clin Oncol 2003; 21:60.

Mandel JS, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328:1365.

Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med 2005; 352:476.

O'Connell MJ, et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 1998; 16:295.

Ratto C, et al. Prognostic factors on colorectal cancer: literature review for clinical application. Dis Colon Rectum 1998; 41:1033.

Rothenberg ML, et al. Superiority of oxaliplatin and fluorouracil- leucovo- rin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil- leucovorin: interim results ofa phase III trial. J Clin Oncol 2003; 21:2059.

Rougier P, et al. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 1998; 352:1407.

Saltz LB, et al. Irinotecan Study Group. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2000; 343:905.

Sauer R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351:1731.

Tournigand C, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004;22:229.

Winawer SJ, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329:1977.

: